Publication
Life Sciences Global Guide
Canada | Publication | oktober 2023
Norton Rose Fulbright lawyers Kristin Wall, Randy Sutton, Veronique Barry, Christopher Guerreiro and Sarah Pennington contributed the Canada chapters to the Practical Law Life Sciences Global Guide on commercialization and regulation. The Guide is published in a Q&A format by Thomson Reuters, which is a leading global platform for trusted, up-to-date legal know how across all major practice areas.
Life Sciences Commercialisation in Canada: Overview
The Q&A Guide to life sciences commercialisation in Canada provides an overview of Canada’s life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.
Life Sciences Regulation in Canada: Overview
The Q&A guide to life sciences regulation in Canada reviews the main legislation governing pharmaceuticals in Canada. The guide provides an overview of key practical issues, including clinical trials, manufacturing, marketing, abridged procedures, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, and natural health products.
Recent publications
Publication
The 2025 Dutch tax plan: Impact on real estate sector
On 17 September 2024, the Dutch Ministry of Finance published its 2025 Tax Plan (Belastingplan 2024). The plan contains several proposals that affect the Dutch real estate sector.
Publication
The 2025 Dutch tax plan: Impact on businesses
Today, 17 September 2024, the Dutch Ministry of Finance published its 2025 Tax Plan (Belastingplan 2025). The plan contains several proposals that affect businesses operating in or with the Netherlands. Most provisions of the 2025 Tax Plan will enter into force on 1 January 2025 (unless otherwise indicated).
Subscribe and stay up to date with the latest legal news, information and events . . .